SANOFI has been ordered to pay
€40.6m in penalties for a “smear
campaign” in France targeting
generic versions of Plavix.
The French competition authority
alleged that Sanofi’s sales force
criticised the generics when talking
with pharmacists and doctors in
2009 and 2010, as well as urging
medical practitioners not to allow
substitution on prescriptions.
Plavix was the most costly
medicine for France’s health system
in 2008, costing €625m.
Sanofi said it’s “reviewing all the
points to prepare an appeal”.The above article was sent to subscribers in Pharmacy Daily's issue from 16 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 May 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.